Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board ...

Beth Marsh will lead commercialization for Neurotech, which gained FDA approval for its eye disease therapy. Neurotech in May ...

Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...

"We are pleased to welcome Eric as Calidi's new CEO, given his deep experience in life science leadership with a focus on oncology, as Calidi advances its systemic enveloped virotherapy platform to ...

Representative Thomas Romeo Quioh of Sinoe County’s Electoral District-1 has admitted his connection to a shady logging ...

Hundreds of pages of documents describing the Legacy deal, and interviews with health care experts and OHSU insiders, reveal ...

Additionally, Ajit Singh, M.S., Ph.D., will join Harbinger's Board of Directors. Dr. Singh is a partner at Artiman Ventures with extensive expertise leading and advising healthcare organizations ...

LGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) announced that it had identified a suitor to take its subsidiary Pelthos Therapeutics public in an April 17th press ...

Endocrine diseases pose significant health challenges, often contributing to premature morbidity and mortality. Traditional Randomized Controlled Trials ...

Under a Biden administration effort, companies would not have been able to sell turkey or chicken meat that exceeded an acceptable level of the bacteria, which is known to cause food poisoning. Also, ...

After much volatility because of Trump's trade war, the stock markets responded positively to a softened tone toward both ...

The Anti-Defamation League has called on a local California school board to apologize after two of its members attacked the Jewish community in comments at a meeting last week. The controversy is ...